Speakers

Jenessa Smith

Associate Director of Process Development • Arsenal Bio

Jenessa trained at the University of Pennsylvania under Daniel J. Powell Jr., studying CAR/TCR T cell product development. Jenessa also started a veterinary clinical trial for CD20-CART treatment of lymphoma in pet dogs in collaboration with Nicola Mason. After finishing her PhD, she spent time in San Diego at Poseida Therapeutics and moved up to San Francisco in 2019. Jenessa’s current team is responsible for end-to-end process development for Arsenal Bioscience’s CART pipeline.

Also Speaking

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

Peter Danforth

Business Development Manager • Wacker Chemie

Mark Sawicki

Chief Executive Officer • Cryoport Systems

Event Info

Image

Fun Run